Kathryn Phillips, PhD, discusses insurance coverage for genomic testing in her recent articles published in JAMA and Science.

In a JAMA Viewpoint, April 16, Phillips examines the new CMS coverage policy for genomic tests in cancer patients: “Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning?”

In a letter in Science, April 20, she considers: “Insurance coverage for genomic tests.”

Phillips is a faculty member in the Department of Clinical Pharmacy. She is a health services and policy researcher and health economist, and the founding director of the TRANSPERS Center (Center for Translational and Policy Research on Personalized Medicine).